About Generate:Biomedicines

What does Generate:Biomedicines do?

Generate:Biomedicines is a provider of a machine learning-powered platform to create new drugs on demand across biologic modalities, accelerating therapeutic identification and validation; Chroma, an open-source AI model that programs novel proteins with targeted properties; and a clinical pipeline (GB-0895 for asthma, GB-0669 targeting SARS-CoV-2), with an expanded collaboration with Amgen to develop novel proteins.

Who are Generate:Biomedicines's competitors?

Generate:Biomedicines's competitors and similar companies include Mucosis, MYR Pharma, Altesa BioSciences, Elion Therapeutics, and Agenovir.

Where is Generate:Biomedicines headquartered?

Generate:Biomedicines is headquartered in United States.

How many employees does Generate:Biomedicines have?

Generate:Biomedicines has 1,000 employees 🔒.

When was Generate:Biomedicines founded?

Generate:Biomedicines was founded in 2010 🔒.

What sector and industry vertical is Generate:Biomedicines in?

Generate:Biomedicines is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Generate:Biomedicines

Who are the top strategic acquirers in Generate:Biomedicines's sector and industry

Top strategic M&A buyers and acquirers in Generate:Biomedicines's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Generate:Biomedicines?

Top strategic M&A buyers groups and sectors for Generate:Biomedicines include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Generate:Biomedicines's sector and industry vertical

Which are the top PE firms investing in Generate:Biomedicines's sector and industry vertical?

Top PE firms investing in Generate:Biomedicines's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Generate:Biomedicines's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Generate:Biomedicines's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Generate:Biomedicines's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Generate:Biomedicines include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Generate:Biomedicines's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Generate:Biomedicines?

The key public trading comparables and valuation benchmarks for Generate:Biomedicines include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Generate:Biomedicines for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Generate:Biomedicines with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Generate:Biomedicines's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Generate:Biomedicines with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Generate:Biomedicines's' sector and industry vertical?

Access recent funding rounds and capital raises in Generate:Biomedicines's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.